kabutan

Takeda Pharmaceutical Company Limited(4502) Summary

4502
TSE Prime
Takeda Pharmaceutical Company Limited
4,414
JPY
-59
(-1.32%)
Dec 5, 2:21 pm JST
28.51
USD
Dec 5, 12:21 am EST
Result
PTS
outside of trading hours
4,414.2
Dec 5, 2:21 pm JST
Summary Chart Historical News Financial Result
PER
45.5
PBR
0.98
Yield
4.53%
Margin Trading Ratio
18.16
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
4,443 JPY 28.64 USD
Previous Close Dec 4
4,473 JPY 28.78 USD
High Dec 5, 9:00 am
4,462 JPY 28.76 USD
Low Dec 5, 12:35 pm
4,400 JPY 28.36 USD
Volume
1,883,900
Trading Value
8.33B JPY 0.05B USD
VWAP
4421.05 JPY 28.56 USD
Minimum Trading Value
441,400 JPY 2,851 USD
Market Cap
7.02T JPY 0.05T USD
Number of Trades
3,119
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
High
1-Year Average
5,314
1-Year High Apr 7, 2025
25,323
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 167,400 1,112,700 6.65
Nov 21, 2025 124,700 1,336,600 10.72
Nov 14, 2025 140,200 1,422,600 10.15
Nov 7, 2025 44,300 2,228,100 50.30
Oct 31, 2025 71,500 2,203,700 30.82
Company Profile
Takeda Pharmaceutical Company Limited is a leading pharmaceutical company. With the acquisition of Shire, it has become a global industry leader. The company focuses on prescription drugs and is strengthening its development of new cancer medications.
Sector
Pharmaceuticals
Takeda Pharmaceutical Company Limited's main business is the research, development, manufacturing, and sales of pharmaceuticals, with a focus on key business areas including gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. The company's research and development efforts are concentrated on three areas: innovative biopharmaceuticals in the priority disease areas of gastroenterology and inflammatory diseases, neuroscience, and oncology, along with plasma-derived therapies and vaccines. Takeda is also committed to rare diseases. The company invests in new research and development capabilities and next-generation platforms, leveraging data and digital technologies to enhance innovation quality and accelerate execution. In Japan, Takeda conducts all operations from research and development to sales in-house, while overseas subsidiaries and affiliates handle manufacturing and sales functions in their respective countries.